abstract |
Compounds of Formula (I): n n n n n n n n n n wherein R 1 to R 11 , A and X 1 to X 3 are as described in the specification, and their salts, are activators of glucokinase (GLK) and are thereby useful in the treatment of, for example, type 2 diabetes. Processes for preparing compounds of Formula (I) are also described. |